Funded Grants

ALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death.

Amyotrophic lateral sclerosis (ALS) is a terminal disease of nerves and muscles. From the time of symptom onset, people with ALS live about 3-5 years.

Rodent models offer an opportunity to understand the computations performed in neural circuits at a much precise scale than using human neuroimaging.

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating neurodegenerative diseases which have overlap in pathological features and the genetic basis.

The fight against ALS is made extremely challenging due to its largely unknown origin in most patients.

Depression is one of the most common mental health challenges faced by young people, yet choosing the right treatment remains a process of trial and error.

ALS is a devastatingly fatal neurodegenerative disease with patients losing their ability to walk, talk, eat, and interact with their loved ones.

Amyotrophic lateral sclerosis (known as ALS or Lou Gehrig’s disease) is a debilitating disease that causes loss of control over muscles and leads to death quickly after diagnosis.

Brain cancer is rarely curative and urgently needs novel transformative treatments.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects the human motor system, leading to muscle weakness and ultimately paralysis.